Fulgent Genetics Reports Second Quarter 2017 Financial Results
07. August 2017 16:05 ET
|
Fulgent Genetics, Inc.
Revenue grows 17% year over year to $4.6 MillionGAAP Loss of $25,000, or $0.00 per ShareNon-GAAP Income of $284,000, or $0.02 per ShareAdjusted EBITDA of $685,000 TEMPLE CITY, Calif., Aug. 07, 2017 ...
Fulgent Genetics to Announce Second Quarter 2017 Financial Results on August 7, 2017
31. Juli 2017 08:30 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., July 31, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its second quarter 2017...
Fulgent Genetics Reports First Quarter 2017 Financial Results
08. Mai 2017 16:05 ET
|
Fulgent Genetics, Inc.
Revenue grows 54% year over year to $5.3 MillionGAAP Income of $0.2 Million, or $0.01 per ShareNon-GAAP Income of $0.6 Million, or $0.03 per ShareAdjusted EBITDA of $1.2 MillionCash Flow from...
Fulgent Genetics to Announce First Quarter 2017 Financial Results on May 8, 2017
25. April 2017 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., April 25, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that its first quarter 2017 financial results will...
Fulgent Genetics Reports Fourth Quarter and Full Year 2016 Financial Results
27. Februar 2017 16:05 ET
|
Fulgent Genetics, Inc.
Fourth Quarter Revenue doubles year over year to $5.9 Million and reaches $18.3 Million for the Full Year of 2016Fourth Quarter 2016 GAAP Income totals $0.8 Million, or $0.05 per ShareFourth Quarter...
Fulgent Genetics to Participate in 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference
27. Februar 2017 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) today announced that Ming Hsieh, Chairman and Chief Executive Officer, and Paul Kim, Chief Financial...
Fulgent Genetics to Announce Fourth Quarter and Full Year 2016 Financial Results on February 27, 2017
08. Februar 2017 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (Nasdaq:FLGT) (“Fulgent Genetics” or the “company”) today announced that its fourth quarter and full year 2016...
Fulgent Genetics, Inc. to Participate in Fireside Chat at the 28th Annual Piper Jaffray Healthcare Conference on November 29, 2016
15. November 2016 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (Nasdaq:FLGT) today announced that Ming Hsieh, Chairman and Chief Executive Officer, and Paul Kim, Chief Financial...
Fulgent Genetics Reports Financial Results for the Third Quarter of 2016
03. November 2016 16:05 ET
|
Fulgent Genetics, Inc.
Revenue Grows 72% to $5.0 Million Over Third Quarter of Last YearGAAP Net Loss of $1.0 Million; non-GAAP Earnings of $1.1 MillionGross Margin, Adjusted EBITDA and Cash Flow Continue to Grow TEMPLE...
Fulgent Genetics, Inc. to Announce Third Quarter 2016 Financial Results on November 3, 2016
26. Oktober 2016 08:05 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (Nasdaq:FLGT) (“Fulgent Genetics” or the “company”) today announced that its third quarter 2016 financial results...